drugset / Trial / NCT05264727
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
Phase 4
Active not recruiting
30 enrolled
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedCrossoverOpen-labelBasic science
Summary
This study is being done to better understand how amino acids alter the release of glucagon and insulin compared to glucose alone in health and disease.
Timeline
- Start
- 2023-05-30
- Primary completion
- 2025-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clinisol 15% | Unknown | 0.003 unknown | Intravenous |
| Subject | Dextrose | Unknown | 8 mg/kg | Intravenous |